Thus, and to the best of our knowledge, our study is the first to report that targeting SOCE can influence the TLR4-induced migration and proliferation of breast cancer cells, as well as the production of inflammatory and cancer-related genes in these cells. The gene discussed is TLR4; the disease is cancer.